Takashima, Y., Sasaki, Y., Hayano, A., Homma, J., Fukai, J., Iwadate, Y., . . . Yamanaka, R. (2018). Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma. Oncotarget.
Chicago Stili AlıntıTakashima, Yasuo, et al. "Target Amplicon Exome-sequencing Identifies Promising Diagnosis and Prognostic Markers Involved in RTK-RAS and PI3K-AKT Signaling As Central Oncopathways in Primary Central Nervous System Lymphoma." Oncotarget 2018.
MLA AlıntıTakashima, Yasuo, et al. "Target Amplicon Exome-sequencing Identifies Promising Diagnosis and Prognostic Markers Involved in RTK-RAS and PI3K-AKT Signaling As Central Oncopathways in Primary Central Nervous System Lymphoma." Oncotarget 2018.